• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

对庆大霉素对耐甲氧西林金黄色葡萄球菌、甲氧西林敏感金黄色葡萄球菌和万古霉素中介金黄色葡萄球菌临床分离株的活性评估。

Evaluation of apramycin activity against methicillin-resistant, methicillin-sensitive, and vancomycin-intermediate Staphylococcus aureus clinical isolates.

作者信息

Truelson Katherine A, Brennan-Krohn Thea, Smith Kenneth P, Kirby James E

机构信息

Boston University, Boston, MA, USA.

Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

出版信息

Diagn Microbiol Infect Dis. 2018 Oct;92(2):168-171. doi: 10.1016/j.diagmicrobio.2018.05.018. Epub 2018 May 29.

DOI:10.1016/j.diagmicrobio.2018.05.018
PMID:29934071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6131043/
Abstract

We evaluated the in vitro activity of apramycin against clinical strains of vancomycin-intermediate and methicillin-resistant and -susceptible Staphylococcus aureus. Apramycin demonstrated an MIC/MIC of 8/16 μg/mL. No strains had an MIC above the epidemiological cutoff value of 32 μg/mL, suggesting apramycin resistance mechanisms are rare in this strain population. The mounting evidence for broad-spectrum in vitro activity of apramycin against S. aureus and other bacterial species suggests that further exploration of apramycin or derivatives as repurposed human therapeutics is warranted.

摘要

我们评估了阿普拉霉素对万古霉素中介型、耐甲氧西林和甲氧西林敏感的金黄色葡萄球菌临床菌株的体外活性。阿普拉霉素的最低抑菌浓度/最低杀菌浓度为8/16μg/mL。没有菌株的最低抑菌浓度高于32μg/mL的流行病学临界值，这表明在该菌株群体中阿普拉霉素耐药机制很少见。越来越多的证据表明阿普拉霉素对金黄色葡萄球菌和其他细菌具有广谱体外活性，这表明有必要进一步探索将阿普拉霉素或其衍生物用作重新利用的人类治疗药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fb/6131043/c882f93a7e8e/nihms976625f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fb/6131043/02ae70b08a86/nihms976625f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fb/6131043/c882f93a7e8e/nihms976625f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fb/6131043/02ae70b08a86/nihms976625f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fb/6131043/c882f93a7e8e/nihms976625f2.jpg

相似文献

1
Evaluation of apramycin activity against methicillin-resistant, methicillin-sensitive, and vancomycin-intermediate Staphylococcus aureus clinical isolates.对庆大霉素对耐甲氧西林金黄色葡萄球菌、甲氧西林敏感金黄色葡萄球菌和万古霉素中介金黄色葡萄球菌临床分离株的活性评估。
Diagn Microbiol Infect Dis. 2018 Oct;92(2):168-171. doi: 10.1016/j.diagmicrobio.2018.05.018. Epub 2018 May 29.
2
Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.阿普拉霉素对多重耐药鲍曼不动杆菌和铜绿假单胞菌的体外活性。
Diagn Microbiol Infect Dis. 2017 Jun;88(2):188-191. doi: 10.1016/j.diagmicrobio.2017.03.006. Epub 2017 Mar 16.
3
Evaluation of apramycin against spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae.评估大观霉素对大观霉素耐药和敏感淋病奈瑟菌的作用。
J Antimicrob Chemother. 2019 May 1;74(5):1311-1316. doi: 10.1093/jac/dkz012.
4
Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.利奈唑胺与其他五种抗菌药物对耐甲氧西林金黄色葡萄球菌、耐甲氧西林表皮葡萄球菌和耐万古霉素粪肠球菌医院分离株的体外活性比较
J Chemother. 2003 Oct;15(5):442-8. doi: 10.1179/joc.2003.15.5.442.
5
Evaluation of apramycin activity against carbapenem-resistant and -susceptible strains of Enterobacteriaceae.阿普拉霉素对耐碳青霉烯类和对碳青霉烯类敏感的肠杆菌科菌株的活性评估。
Diagn Microbiol Infect Dis. 2016 Dec;86(4):439-441. doi: 10.1016/j.diagmicrobio.2016.09.002. Epub 2016 Sep 8.
6
Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.伊朗西北部从临床标本中分离出的耐甲氧西林金黄色葡萄球菌中出现了万古霉素中介和耐药金黄色葡萄球菌。
J Glob Antimicrob Resist. 2018 Sep;14:4-9. doi: 10.1016/j.jgar.2018.01.017. Epub 2018 Feb 14.
7
Interactions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility.耐甲氧西林金黄色葡萄球菌菌株中，甲氧西林与万古霉素之间的相互作用表现出不同的万古霉素敏感性表型。
J Clin Microbiol. 1999 Sep;37(9):3068-71. doi: 10.1128/JCM.37.9.3068-3071.1999.
8
Proposal of Epidemiological Cutoff Values for Apramycin 15 μg and Florfenicol 30 μg Disks Applicable to .大观霉素 15μg 和氟苯尼考 30μg 纸片法的流行病学截断值的建议 。
Microb Drug Resist. 2021 Nov;27(11):1555-1559. doi: 10.1089/mdr.2020.0402. Epub 2021 May 5.
9
Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative.对甲氧西林敏感的万古霉素异质性中间型金黄色葡萄球菌临床分离株及耐万古霉素衍生物的体外筛选
Antimicrob Agents Chemother. 2001 Jan;45(1):349-52. doi: 10.1128/AAC.45.1.349-352.2001.
10
Antibiotic susceptibility and phage typing of methicillin-resistant and -sensitive Staphylococcus aureus clinical isolates at three periods during 1991-1997.1991年至1997年三个时间段耐甲氧西林和对甲氧西林敏感的金黄色葡萄球菌临床分离株的抗生素敏感性及噬菌体分型
Eur J Clin Microbiol Infect Dis. 2001 Jun;20(6):425-7. doi: 10.1007/pl00011284.

引用本文的文献

1
Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects.抗生素肺部给药：现状与未来展望
Pharmaceutics. 2025 Jan 15;17(1):111. doi: 10.3390/pharmaceutics17010111.
2
Synthesis of 4--(4-Amino-4-deoxy-β-D-xylopyranosyl)paromomycin and 4--(β-D-Xylopyranosyl)-4-deoxy-4'-thio-paromomycin and Evaluation of their Antiribosomal and Antibacterial Activity.4-（4-氨基-4-脱氧-β-D-吡喃木糖基）巴龙霉素和4-（β-D-吡喃木糖基）-4-脱氧-4'-硫代巴龙霉素的合成及其抗核糖体和抗菌活性评估
Tetrahedron. 2023 Apr 6;135. doi: 10.1016/j.tet.2023.133330. Epub 2023 Feb 23.
3
Synthesis, Antibacterial and Antiribosomal Activity of the 3-Aminoalkyl Modification in the Ribofuranosyl Ring of Apralogs (5--Ribofuranosyl Apramycins).

本文引用的文献

1
Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh Model.安普霉素对中性粒细胞减少症小鼠大腿模型中多药耐药鲍曼不动杆菌的疗效。
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02585-17. Print 2018 Apr.
2
Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.喷墨打印机技术筛选针对碳青霉烯类耐药肠杆菌科的抗菌药物组合协同活性。
J Antimicrob Chemother. 2017 Oct 1;72(10):2775-2781. doi: 10.1093/jac/dkx241.
3
Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
阿普拉洛格（5--呋喃核糖基阿泊拉霉素）呋喃核糖环中3-氨基烷基修饰的合成、抗菌及抗核糖体活性
Antibiotics (Basel). 2022 Dec 24;12(1):25. doi: 10.3390/antibiotics12010025.
4
Importance of Co-operative Hydrogen Bonding in the Apramycin-Ribosomal Decoding A-Site Interaction.氨甲酰基霉素与核糖体解码 A 位相互作用中协同氢键的重要性。
ChemMedChem. 2023 Jan 3;18(1):e202200486. doi: 10.1002/cmdc.202200486. Epub 2022 Oct 28.
5
Population pharmacokinetics of apramycin from first-in-human plasma and urine data to support prediction of efficacious dose.首个人体血浆和尿液数据的壮观霉素群体药代动力学研究，支持有效剂量预测。
J Antimicrob Chemother. 2022 Sep 30;77(10):2718-2728. doi: 10.1093/jac/dkac225.
6
Repurposing the Veterinary Antibiotic Apramycin for Antibacterial and Antibiofilm Activity Against From Cystic Fibrosis Patients.将兽用抗生素阿普拉霉素重新用于对抗囊性纤维化患者来源的细菌及生物膜活性。
Front Microbiol. 2022 Feb 3;12:801152. doi: 10.3389/fmicb.2021.801152. eCollection 2021.
7
Translation error clusters induced by aminoglycoside antibiotics.氨基糖苷类抗生素引起的翻译错误簇。
Nat Commun. 2021 Mar 23;12(1):1830. doi: 10.1038/s41467-021-21942-6.
8
Epidemiologic, Phenotypic, and Structural Characterization of Aminoglycoside-Resistance Gene .氨基糖苷类耐药基因的流行病学、表型和结构特征。
Int J Mol Sci. 2020 Aug 25;21(17):6133. doi: 10.3390/ijms21176133.
9
Wild-type cutoff for Apramycin against Escherichia coli.阿帕霉素对大肠杆菌的野生型截止值。
BMC Vet Res. 2020 Aug 26;16(1):309. doi: 10.1186/s12917-020-02522-0.
10
Activity of Apramycin Against Carbapenem-Resistant and Hypervirulent Isolates.阿泊拉霉素对碳青霉烯类耐药及高毒力菌株的活性
Front Microbiol. 2020 Mar 13;11:425. doi: 10.3389/fmicb.2020.00425. eCollection 2020.
阿普拉霉素对多重耐药鲍曼不动杆菌和铜绿假单胞菌的体外活性。
Diagn Microbiol Infect Dis. 2017 Jun;88(2):188-191. doi: 10.1016/j.diagmicrobio.2017.03.006. Epub 2017 Mar 16.
4
Evaluation of apramycin activity against carbapenem-resistant and -susceptible strains of Enterobacteriaceae.阿普拉霉素对耐碳青霉烯类和对碳青霉烯类敏感的肠杆菌科菌株的活性评估。
Diagn Microbiol Infect Dis. 2016 Dec;86(4):439-441. doi: 10.1016/j.diagmicrobio.2016.09.002. Epub 2016 Sep 8.
5
Verification of an Automated, Digital Dispensing Platform for At-Will Broth Microdilution-Based Antimicrobial Susceptibility Testing.基于肉汤微量稀释法的随意性抗菌药物敏感性试验自动数字配药平台的验证
J Clin Microbiol. 2016 Sep;54(9):2288-93. doi: 10.1128/JCM.00932-16. Epub 2016 Jun 22.
6
Validation of a High-Throughput Screening Assay for Identification of Adjunctive and Directly Acting Antimicrobials Targeting Carbapenem-Resistant Enterobacteriaceae.用于鉴定针对耐碳青霉烯类肠杆菌科细菌的辅助性和直接作用抗菌药物的高通量筛选测定法的验证
Assay Drug Dev Technol. 2016 Apr;14(3):194-206. doi: 10.1089/adt.2016.701. Epub 2016 Apr 5.
7
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.金黄色葡萄球菌感染：流行病学、病理生理学、临床表现及管理
Clin Microbiol Rev. 2015 Jul;28(3):603-61. doi: 10.1128/CMR.00134-14.
8
Validation of drop plate technique for bacterial enumeration by parametric and nonparametric tests.通过参数检验和非参数检验验证用于细菌计数的倾注平板技术。
Vet Res Forum. 2013 Summer;4(3):179-83.
9
In vivo efficacy of apramycin in murine infection models.阿普拉霉素在小鼠感染模型中的体内疗效。
Antimicrob Agents Chemother. 2014 Nov;58(11):6938-41. doi: 10.1128/AAC.03239-14. Epub 2014 Aug 18.
10
Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin.4-单取代 2-去氧链霉胺氨基糖苷类抗生素的抗菌活性和耳毒性的分离。
Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):10984-9. doi: 10.1073/pnas.1204073109. Epub 2012 Jun 14.